Cargando…
Diagnosis and management of monoclonal gammopathy of clinical significance
The term “monoclonal gammopathy of clinical significance” (MGCS) refers to any plasma cell or B-cell clonal disorder that does not meet the current criteria for malignant disorders but produces a monoclonal protein that directly or indirectly results in organ damage. The most commonly affected organ...
Autor principal: | Cho, Hyungwoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057659/ https://www.ncbi.nlm.nih.gov/pubmed/35483921 http://dx.doi.org/10.5045/br.2022.2022035 |
Ejemplares similares
-
The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance
por: Castillo, Jorge J., et al.
Publicado: (2021) -
IgM monoclonal gammopathies of clinical significance: diagnosis and management
por: Khwaja, Jahanzaib, et al.
Publicado: (2022) -
MONOCLONAL GAMMOPATHY OF CLINICAL SIGNIFICANCE
por: Bladé, J.
Publicado: (2023) -
Monoclonal Gammopathy of Thrombotic Significance
por: Gkalea, Vasiliki, et al.
Publicado: (2023) -
Treatment of Patients with Monoclonal Gammopathy of Clinical Significance
por: Moreno, David F., et al.
Publicado: (2021)